Burning Rock Biotech focuses on providing individualized cancer treatment guidance for the patients.
Burning Rock, founded in March, 2014 and headquartered in Beijing, is a tumor precision individualized medical clinical testing service organization. Established by Han Yusheng, Xu Shaokun and Wu Zhigang, the company has received financings from LYFE Capital, Sequoia Capital, Legend Star and so on. Rivals that have direct and indirect competition with Burning Rock globally include Yahui Biotechnology, Autobio, Danaher, etc.
ResearchReal Estate, Consumer Discretionary, Industrials
Tech for Global, Globalization Footprints of the Established and the New
ResearchConsumer Staples, Industrials, Financials
Low-Carbon Industry Expansion - Key Studies From Chinese Companies
After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
The early-stage cancer-detection technology has declared its mission: to take on and defeat the fatal illness, for the benefit of humanity. Following Burning Rock and Genetron Health, the US biotech GRAIL looks to go public on Nasdaq.
Sep 10, 2020 11:48 AM
Burning Rock Hits NASDAQ, Still Struggles to Make a Profit
NASDAQ welcomes its first Chinese NGS cancer detection company, Burning Rock. The company owns the largest market share in Chinese NGS market but still hasn’t begun to profit. What is the cause and how long does it still need?
Jun 19, 2020 10:20 AM
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- China Speed: Two COVID-19 Vaccines Recognized by WHO
- Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
- More Room for the Medical Device Market to Grow in China
- Tong Ren Tang: Any Hope for this Purveyor of Centuries-Old Chinese Medicines?